SUMMARY The ELISA technique has been found to be reliable for the detection and titration of cytomegalovirus-specific IgG antibody in serum. It is about six times more sensitive than the CF test although some discrepancies were found between the antibody titres determined by the two methods. (Dienstag et al., 1976) , and radioimmunoassay (Forghani et al., 1976; Knez et al., 1976) , have also been used and found to be satisfactory but have not been generally adopted.
essential medium with 10% fetal calf serum at 37'C. After 7-10 days, when gross cytopathic effects had developed, the cells were scraped off the bottles into a small volume of phosphate-buffered saline (PBS), pH 7-2, washed three times in PBS, and resuspended in a volume of 0-1 M glycine-NaClNaOH buffer, pH 10, equivalent to a final concentration of 1 ml per culture bottle of cells. The concentrated cells were immediately disrupted by ultrasonication for 5 s and the cellular debris was removed by centrifugation at 800 g for 10 min. The final supernatant was stored, in 0 25 ml quantities, at -70'C. Control antigen was prepared in the same way from uninfected MRC-5 cells. These antigens were used for both the CF and ELISA tests.
COMPLEMENT-FIXATION TEST
This was carried out by the microtitre technique (Sever, 1962) with 2 units of antigen and 3 MHD5o of complement. Antibody titres were read as the reciprocal of the highest dilution of serum giving 50% (2+) fixation. ELISA PROCEDURE This was done by the method . Flat-bottomed wells in polystyrene microtitre plates (Cooke Microtitre M29AR, Dynatech Ltd) were coated with viral or control antigen by the addition of 0 3 ml of the antigen, diluted to optimal concentration in 01 M carbonate-bicarbonate buffer, pH 9-6, and incubated overnight. The plates were then washed three times in PBS containing 0 05% Tween 20 and 0-02 % NaN3 (PBST) and shaken dry. They were used immediately or after storage at -70°C (stored plates were found to be satisfactory 122
Comparison of enzyme-linked immunosorbent assay (ELJSA) technique even after nine months). Test sera were diluted in PBST, and 0 3 ml of each dilution was added to duplicate wells. The plates were incubated overnight at 40C, washed three times in PBST, and shaken dry. Conjugate was then added, in 0 3 ml amounts, and the plates were left for 2 h at room temperature. After three further washes in PBST, 0 3 ml of the substrate was added to each well. Exactly 30 min later the reaction was stopped by the addition of 0 05 ml of 3 M NaOH. The intensity of the colour change produced in the substrate was measured at 400 nm in a Gilford 300-T-1 spectrophotometer with a vacuum-aspirated microcuvette accessory. The absorbance (E400) for each serum sample was calculated as the mean of the duplicate readings minus the'background' activity in the test; the latter was measured as the mean of the readings from four duplicate wells incubated with PBST instead of serum. The ELISA antibody titre of each of the 29 sera was measured, from their curves described above, as the reciprocal of the dilution that had an E400 value of 0-5, and this was plotted on a graph against the E400 value obtained for a 1 in 300 dilution of the same serum (Fig. 3) ; 1 in 300 was chosen as a suitable dilution from Fig. 2 , which showed that it lay on the linear part of curves representing both high-titred and low-titred antisera. A straightline, directly proportional relationship was obtained (correlation coefficient r = 0 93, P < 0-001), confirming that the antibody titre of a serum could be reliably calculated from the E400 value of a single 1 in 300 dilution. The lowest E400 reading among the 29 positive sera examined at this dilution was 0-22; the readings for the four negative sera were all < 0-09; 1 in 300 was, therefore, used as the standard test dilution for sera in subsequent experiments.
COMPARISON OF ELISA AND CF TESTS FOR DETECTION OF ANTIBODY
A single batch of antigen was used to examine the 29 CMV-antibody-positive antisera described above by both the ELISA and the CF techniques. The results obtained by the two techniques, that is, the E400 values at a 1 in 300 dilution and the CF antibody titres, showed good correlation (r = 0 73, P < 0-001) (Fig. 4) , although a few sera with .almost identical E400 values had CF antibody titres and E400 values, at a 1 in 300 dilution, of 0-040-13 i (mean 0-08, standard deviation 0-03). Sixty-nine t sera had CF antibody titres of 16-8192 and E400 _ values of 0-24-2-32. Again there was good general n agreement between the two tests (r = 0-62, P < 0 001), but some scatter of results (Fig. 5) . Sera with ' CF antibody titres of 64 or less had E400 values of -<1 0, and those with titres of > 1024 had E400 values of >1V0, but among the sera with inter-LL mediate CF antibody titres of 128-1024 there was a scatter of E400 values, ranging from 0-24 to 2-0. c However, examination by ELISA at a 1 in 300 z dilution effectively discriminates between antibody-4 negative sera (CF antibody titre <8, E400 <0-2) and antibody-positive sera (CF > 16, E400 > 0 2). None of the 90 sera showed any significant reactivity in either the CF or ELISA tests against control, uninfected antigen; they were negative for rheumatoid factor when tested at a 1 in 10 (Schmitz et al., 1977) , and that it is 25 comparable in sensitivity to the indirect immunofluorescence test (Schmitz et al., 1977) and 2-to 10-E fold more sensitive than the indirect haemagglutination test (Castellano et al., 1977 (Stanford, 1972; Haukenes, 1974) . Another possibility was the presence in the antigen preparations of the nonspecific, intracytoplasmic F, receptor that develops in CMV-infected cells (Sakuma et al., 1977) . Extracted receptor protein could perhaps attach to the microtitre wells and give spuriously enhanced E400 readings due to reaction with antibody other than CMV antibody; Fc receptor-antibody complexes do not fix complement and would not interfere with the CF test. This was excluded, however, by the lack of significant reaction in the ELISA test with CMV antibody-negative sera. The simplest explanation would be that human sera contain variable mixtures of CMV IgG antibodies (Cremer et al., 1975) , only some of which readily fix complement, whereas the ELISA technique, based on a globulin-antiglobulin reaction mechanism, has a much wider recognition range for antibody. Unfortunately, IgG antibodies that do not fix complement have not been described for CMV, but since similar discrepancies have been recognised between the CF test and both the indirect and anticomplement immunofluorescence techniques (Griffiths et al., 1978) , they deserve further investigation. 
